Pamrevlumab for IPF, Dapagliflozin in Critical Illness, Payer Involvement in Evidence Generation, and more

JAMA Editors' Summary - Un pódcast de JAMA Network - Viernes

Podcast artwork

Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the August 6, 2024, issue.

Visit the podcast's native language site